Use of precision-cut renal cortical slices in nephrotoxicity studies

References

• Bach PH, Lock EA. (1982). The use of renal tissue slices, perfusion and infusion techniques to assess nephrotoxicity related changes. In: Bach PH, Bonner FW, Bridges JW, Lock EA, eds. Nephrotoxicity: Assessment and Pathogenesis. New York: John Wiley & Sons, 128–143.
   Google Scholar
• Bach PH, Vickers AEM, Fisher R, Baumann A, Brittebo E, Carlile DJ, Koster HJ, Lake BG, Salmon F, Sawyer TW, Skibinski G. (1996). The use of tissue slices for pharmacotoxicology studies – The report and recommendations of ECVAM workshop 20. Altern Lab Anim 24:893–923.
   Web of Science ®Google Scholar
• Baverel G, Bonnard M, D’Armagnac de Castanet E, Pellet M. (1978). Lactate and pyruvate metabolism in isolated renal tubules of normal dogs. Kidney Int 14:567–575.
   PubMed Web of Science ®Google Scholar
• Baverel G, Lund P. (1979). A role for bicarbonate in the regulation of mammalian glutamine metabolism. Biochem J 184:599–606.
   PubMedGoogle Scholar
• Bergmeyer HU, Bernt E. (1974). Lactate dehydrogenase: UV assay with pyruvate and NADH. In: Bergmeyer H, ed. Methods of Enzymatic Analysis. New York: Academic Press, 574–579.
   Google Scholar
• Berndt WO. (1987). Renal slices and perfusion. In: Bach PH, Lock EA, eds. Nephrotoxicity: Assessment and Pathogenesis. New York: John Wiley & Sons, 505–518.
   Google Scholar
• Berry MN, Friend DS. (1969). High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506–520.
   PubMed Web of Science ®Google Scholar
• Canioni P, Alger JR, Shulman RG. (1983). Natural abundance Carbon-13 nuclear magnetic resonance spectroscopy of liver and adipose tissue of the living rat. Biochemistry 22:4974–4980.
   PubMed Web of Science ®Google Scholar
• Conjard A, Dugelay S, Chauvin MF, Durozard D, Baverel G, Martin G. (2002). The anaplerotic substrate alanine stimulates acetate incorporation into glutamate and glutamine in rabbit kidney tubules. A (13)C NMR study. J Biol Chem 277:29444–29454.
   PubMedGoogle Scholar
• Coulter DL, Allen RJ. (1980). Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1:1310–1311.
   PubMed Web of Science ®Google Scholar
• Craft AW, Pearson AD. (1989). Three decades of chemotherapy for childhood cancer: from cure ‘at any cost’ to cure ‘at least cost’. Cancer Surv 8:605–629.
   PubMedGoogle Scholar
• Dechant KL, Brogden RN, Pilkington T, Faulds D. (1991). Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 42:428–467.
   PubMed Web of Science ®Google Scholar
• Dubourg L, Michoudet C, Cochat P, Baverel G. (2001). Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide. J Am Soc Nephrol 12:1615–1623.
   PubMed Web of Science ®Google Scholar
• Dugelay S, Chauvin MF, Megnin-Chanet F, Martin G, Laréal MC, Lhoste JM, Baverel G. (1999). Acetate stimulates flux through the tricarboxylic acid cycle in rabbit renal proximal tubules synthesizing glutamine from alanine: a 13C NMR study. Biochem J 342 Pt 3:555–566.
   PubMedGoogle Scholar
• Durozard D, Baverel G. (1987). Gas chromatographic method for the measurement of sodium valproate utilization by kidney tubules. J Chromatogr 414:460–464.
   PubMed Web of Science ®Google Scholar
• Durozard D, Martin G, Baverel G. (1991). Valproate-induced alterations of coenzyme A and coenzyme A ester concentrations in human kidney tubules metabolizing glutamine. Contrib Nephrol 92:103–108.
   PubMedGoogle Scholar
• Elhamri M, Ferrier B, Martin M, Baverel G. (1993). Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat. J Pharmacol Exp Ther 266:89–96.
   PubMedGoogle Scholar
• Ferrier B, Martin M, Baverel G. (1988). Valproate-induced stimulation of renal ammonia production and excretion in the rat. J Clin Chem Clin Biochem 26:65–67.
   PubMedGoogle Scholar
• Goren MP, Pratt CB, Viar MJ. (1989). Tubular nephrotoxicity during long-term ifosfamide and mesna therapy. Cancer Chemother Pharmacol 25:70–72.
   PubMedGoogle Scholar
• Goren MP, Wright RK, Pratt CB, Horowitz ME, Dodge RK, Viar MJ, Kovnar EH. (1987). Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy. Cancer Res 47:1457–1460.
   PubMed Web of Science ®Google Scholar
• Graaf IA, Groothuis GM, Olinga P. (2007). Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin Drug Metab Toxicol 3:879–898.
   PubMed Web of Science ®Google Scholar
• Griffith OW. (1985). Glutathione and glutathione disulfide. In: Bergmeyer HU, Bergmeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Weinheim: VCH Verlagsgesellschaft, 521–529.
   Google Scholar
• Guder WG, Ross BD. (1984). Enzyme distribution along the nephron. Kidney Int 26:101–111.
   PubMed Web of Science ®Google Scholar
• Hirsch GH. (1976). Differential effects of nephrotoxic agents on renal transport and metabolism by use of in vitro techniques. Environ Health Perspect 15:89–99.
   PubMed Web of Science ®Google Scholar
• Howarth OW, Lilley DMJ. (1978). Carbon-13-NMR of peptides and proteins. Prog NMR Spectrosc 12:1–40.
   Web of Science ®Google Scholar
• Knouzy B, Dubourg L, Baverel G, Michoudet C. (2010). Targets of chloroacetaldehyde-induced nephrotoxicity. Toxicol In Vitro 24:99–107.
   PubMed Web of Science ®Google Scholar
• Krebs HA, Henseleit K. (1932). Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seyler’s Zeitschrift für. Physiol Chemie 210:33–66.
   Google Scholar
• Krumdieck CL, dos Santos JE, Ho KJ. (1980). A new instrument for the rapid preparation of tissue slices. Anal Biochem 104:118–123.
   PubMed Web of Science ®Google Scholar
• Lamprecht W, Trautchold I. (1974). Adenosine-5’-triphosphate. Determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer H, ed. Methods of Enzymatic Analysis. New York: Academic Press, 2101–2110.
   Google Scholar
• Latzko E, Gibbs M. (1974). Alkaline C1-fructose-1,6-disphosphatase. In: Bergmeyer HU, Gawehen K, eds. Methods of Enzymatic Analysis. Weinheim: Verlag Chemie, 881–884.
   Google Scholar
• Lerche-Langrand C, Toutain HJ. (2000). Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 153:221–253.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Martin G, Chauvin MF, Baverel G. (1997). Model applicable to NMR studies for calculating flux rates in five cycles involved in glutamate metabolism. J Biol Chem 272:4717–4728.
   PubMedGoogle Scholar
• Martin G, Chauvin MF, Dugelay S, Baverel G. (1994). Non-steady state model applicable to NMR studies for calculating flux rates in glycolysis, gluconeogenesis, and citric acid cycle. J Biol Chem 269:26034–26039.
   PubMedGoogle Scholar
• Nicholson JK, Lindon JC, Holmes E. (1999). ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189.
   PubMed Web of Science ®Google Scholar
• Nissim I, Horyn O, Daikhin Y, Nissim I, Luhovyy B, Phillips PC, Yudkoff M. (2006). Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res 66:7824–7831.
   PubMed Web of Science ®Google Scholar
• Parrish AR, Gandolfi AJ, Brendel K. (1995). Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci 57:1887–1901.
   PubMed Web of Science ®Google Scholar
• Passonneau JV, Lowry OH. (1993). Enzymatic analysis: a practical guide. Totowa: The Humana Press Inc.
   Google Scholar
• Powell-Jackson PR, Tredger JM, Williams R. (1984). Hepatotoxicity to sodium valproate: a review. Gut 25:673–681.
   PubMed Web of Science ®Google Scholar
• Rossi R, Kleta R, Ehrich JH. (1999a). Renal involvement in children with malignancies. Pediatr Nephrol 13:153–162.
   PubMed Web of Science ®Google Scholar
• Rossi R, Pleyer J, Schäfers P, Kuhn N, Kleta R, Deufel T, Jürgens H. (1999b). Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 32:177–182.
   PubMedGoogle Scholar
• Sakai A, Shimizu H, Kono K, Furuya E. (2005). Monochloroacetic acid inhibits liver gluconeogenesis by inactivating glyceraldehyde-3-phosphate dehydrogenase. Chem Res Toxicol 18:277–282.
   PubMedGoogle Scholar
• Shaka AJ, Keeler J, Freeman R. (1983). Evaluation of a New Broad-Band Decoupling Sequence - Waltz-16. J Magn Reson 53:313–340.
   Web of Science ®Google Scholar
• Simon D, Penry JK. (1975). Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia 16:549–573.
   PubMed Web of Science ®Google Scholar
• Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. (1990). Nephrotoxicity after ifosfamide. Arch Dis Child 65:732–738.
   PubMed Web of Science ®Google Scholar
• Stevens MC, Brandis M. (1993). Incidence and etiology of ifosfamide nephrotoxicity: report of a meeting held in Rhodes, Greece, October 3, 1991, sponsored by Asta Medica, Frankfurt, Germany. Med Pediatr Oncol 21:640–644.
   PubMedGoogle Scholar
• Suarez A, Mcdowell H, Niaudet P, Comoy E, Flamant F. (1991). Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors - an International Society of Pediatric Oncology Report. J Clin Oncol 9:2177–21782.
   PubMed Web of Science ®Google Scholar
• Vickers AE, Fisher RL. (2004). Organ slices for the evaluation of human drug toxicity. Chem Biol Interact 150:87–96.
   PubMed Web of Science ®Google Scholar
• Vickers AE, Fisher RL. (2005). Precision-cut organ slices to investigate target organ injury. Expert Opin Drug Metab Toxicol 1:687–699.
   PubMedGoogle Scholar
• Vittorelli A, Gauthier C, Michoudet C, Martin G, Baverel G. (2005). Characteristics of glutamine metabolism in human precision-cut kidney slices: a 13C-NMR study. Biochem J 387:825–834.
   PubMedGoogle Scholar
• Wagner T. (1994). Ifosfamide clinical pharmacokinetics. Clin Pharmacokinet 26:439–456.
   PubMed Web of Science ®Google Scholar
• Warburg O. (1923). Tests on surviving carcinoma cultures. Biochemische Zeitschrift 142:317–333.
   Google Scholar
• Warter JM, Marescaux C, Chabrier G, Rumbach L, Micheletti B, Imler M. (1984). Renal glutamine metabolism in man during treatment with sodium valproate. Rev Neurol (Paris) 140:370–371.
   PubMedGoogle Scholar